APA (7th ed.) Citation

Z, Y., CL, R., C, N., T, H., T, R., PS, J., . . . JB, R. (2016). Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures. Human brain mapping, 37(3), 1026. https://doi.org/10.1002/hbm.23087

Chicago Style (17th ed.) Citation

Z, Ye, et al. "Predicting Beneficial Effects of Atomoxetine and Citalopram on Response Inhibition in Parkinson's Disease with Clinical and Neuroimaging Measures." Human Brain Mapping 37, no. 3 (2016): 1026. https://doi.org/10.1002/hbm.23087.

MLA (9th ed.) Citation

Z, Ye, et al. "Predicting Beneficial Effects of Atomoxetine and Citalopram on Response Inhibition in Parkinson's Disease with Clinical and Neuroimaging Measures." Human Brain Mapping, vol. 37, no. 3, 2016, p. 1026, https://doi.org/10.1002/hbm.23087.